十一月 2025
- Home
- Hikma Pharmaceuticals
十一月 2025的Hikma Pharmaceuticals市场份额分析
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978.
Hikma Pharmaceuticals(包含公司地区分支机构)
查看更多网站流量和参与度信息- hikma.com
Hikma Pharmaceuticals收入截至 十一月 2025为 > 1B
Hikma Pharmaceuticals主要域名产生的收入
3 年中Hikma Pharmaceuticals主要域名的收入
Hikma Pharmaceuticals主要域名的收入
Hikma Pharmaceuticals热门域名的总访问量
了解Hikma Pharmaceuticals市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Hikma Pharmaceuticals热门域名的平均访问时长
分析Hikma Pharmaceuticals参与度指标。
过去 3 个月的平均访问时长
子公司明细
Hikma Pharmaceuticals热门域名的平均页面浏览量
了解Hikma Pharmaceuticals如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Hikma Pharmaceuticals 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Hikma Pharmaceuticals PLC went public on Nov 1st '05.Since its initial public offering in November 2005, Hikma Pharmaceuticals PLC has expanded its global footprint across North America, Europe, and the MENA region.
十一月 20, 2025阅读更多
新闻Hikma Pharmaceuticals PLC invests into assets: pharmaceutical manufacturing and R&D facilities in the amount of $1B in Ohio, United States.Hikma Pharmaceuticals invests $1B to expand pharmaceutical manufacturing and R&D facilities in Ohio and New Jersey
The expansion will grow domestic capacity across four sites and support the production of more than 12 billion doses of essential medicines annually.
十月 23, 2025阅读更多
新闻Hikma Pharmaceuticals PLC partners with bigs4kids.In the United States, Hikma Pharmaceuticals PLC has partnered with nonprofits such as Big Brothers Big Sisters of Central Ohio to renovate learning spaces and The Center for Family Services in New Jersey through Project Backpack to provide essential school supplies to underserved youth.
八月 25, 2025阅读更多
查看 Hikma Pharmaceuticals 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。